Skip to main content

Table 1 Clinical parameters and laboratory test indexes of the study cohort

From: Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy

Variables

HE group

(N = 30)

Cir group

(N = 30)

NC group

(N = 20)

F/χ 2 /t

P

Age

(year)

56.13 ± 13.20

52.23 ± 9.00

44.45 ± 8.46

7.245(F)

0.001

0.161ab

< 0.001ac

0.015bc

Gender

(Male/female)

19/11

20/10

12/8

0.234(χ2)

0.889

BMI

22.53 ± 2.51

22.21 ± 3.24

22.37 ± 2.07

0.106(F)

0.900

Etiology

     

 HBV

 HCV

 Alcoholic

 HBV + alcoholic

 HCV + alcoholic

 Others

9

1

12

1

1

6

14

1

8

3

1

3

 

3.887(χ2)

0.566

Child-Pugh Class

     

 A

 B

 C

0

9

21

9

7

14

 

10.650(χ2)

0.005

Meld-score

19.67 ± 5.95

13.90 ± 6.51

 

3.582(t)

< 0.001

Ascites

     

 None

 Mild

 Moderate

 Severe

2

7

8

13

15

7

2

6

 

16.120(χ2)

< 0.001

Medication history

     

 Non-selective β-blockers

 Lactulose

 Anti-HBV

4(13.33%)

5(13.33%)

9(30.00%)

0(0%)

0(0%)

15((60.00%)

 

Fisher’s Exact Test

Fisher’s Exact Test

2.5(χ2)

0.112

0.052

0.114

Previous variceal bleeding

13(43.33%)

5(16.67%)

 

5.079(χ2)

0.024

Previous TIPs

13(43.33%)

2(6.67%)

 

10.756(χ2)

0.001

Previous HE

6(20.00%)

0(0%)

 

Fisher’s Exact Test

0.024

SBP

11(36.67%3)

3(10.00%)

 

4.565(χ2)

0.033

Creatinine (μmol/L)

74.2(53.95-156.15)

72.35(55.98–84.85)

 

Mann-Whitney U Test

0.487

TBIL (μmol/L)

51.91(27.96–94.53)

28.19 (14.42–56.31)

 

Mann-Whitney U Test

0.012

DBIL (μmol/L)

24.14 (12.84–59.47)

12.98 (6.36–36.20)

 

Mann-Whitney U Test

0.037

IBIL (μmol/L)

22.73 (11.12–45.37)

14.06 (7.54–22.03)

 

Mann-Whitney U Test

0.023

ALT (IU/L)

24.75(15.43–43.13)

44.40 (26.30-60.53)

 

Mann-Whitney U Test

0.006

AST(IU/L)

41.90 (26.88–68.55)

68.30 (47.35–92.48)

 

Mann-Whitney U Test

0.030

Albumin(g/L)

29.47 ± 4.64

31.76 ± 7.44

 

-1.428(t)

0.159

PT(s)

18.85(16.20–22.50)

16.55(13.97–18.50)

 

Mann-Whitney U Test

0.011

INR

1.63 (1.38–2.06)

1.38 (1.10–1.60)

 

U Test

0.004

Ammonia(μmol/L)

92.31 ± 47.51

41.51 ± 18.30

 

5.465(t)

< 0.001

WBC(109/L)

6.10 ± 4.67

5.20 ± 2.16

 

0.965(t)

0.339

Neutrophil(%)

68.70 ± 13.24

65.06 ± 11.22

 

1.148(t)

0.256

CRP

6.54(2.26–18.42)

7.38(1.27-134.98)

 

Mann-Whitney U Test

0.813

Length of stay

(days)

8.50(6.00-15.75)

8.50(7.00-15.50)

 

Mann-Whitney U Test

0.772

90-day mortality

4(13.33%)

0(0%)

 

Fisher’s Exact Test

0.112

90-day recurrence

5(16.67%)

0(0%)

 

Fisher’s Exact Test

0.052

  1. BMI body mass index, HBV hepatitis B virus, HCV hepatitis C virus, Anti-HBV Anti-hepatitis B virus therapy, TIPs transjugular intrahepatic portal-systemic, HE hepatic encephalopathy, SBP spontaneous bacterial peritonitis, TBIL total bilirubin, DBIL direct bilirubin, IBIL indirect bilirubin, ALT alanine transaminase, AST aspartate transaminase, PT prothrombin time, INR international normalized ratio, WBC white blood cell count, CRP C-reactive protein. ab, difference between HE group and Cir group; ac, difference between HE group and NC group; bc, difference between Cir group and NC group